3/21/2025Rhythm Pharma Regains Rights to Obesity Drug in China

3/21/2025Henlius' HER2-Targeting Antibody HLX22 Granted FDA Orphan Drug Designa...

3/21/2025Hengrui's Ivarmacitinib Secures First Approval in China for Ankylosing...

3/21/2025NHSA Releases Its 2024 Statistical Bulletin on Healthcare Security De...

3/21/2025Gilead's Trodelvy Receives Second Approval in China

3/21/2025Huadong Medicine's HDM1002 Advances to Phase III Clinical Trials

3/21/2025Junshi's Toripalimab Receives 11th Approval in China

3/21/2025NMPA Approves Hutchmed's Tazverik for r/r Follicular Lymphoma in China

3/21/2025Recent Executive Moves

3/20/2025Grand Pharma Advances Phase III Trial of ITM-11 in China

3/20/2025Chinese Government Issues Notice on Strengthening Drug Traceability Co...

3/20/2025State Council Issues the Opinion on Enhancing TCM Quality and Promotin...

3/19/2025Hengrui Initiates Phase 2/3 Trial Combining SHR-A2102 and Adebrelimab ...

3/19/2025EU Chamber Urges China to Balance Drug Procurement Priorities amid Pri...

3/19/2025MSD Expands Public Health Efforts in China Following HPV Vaccine Appro...

3/19/2025Shanghai Breaks Ground on National Emergency Medical Center

3/19/2025These 12 Chinese Companies Are Poised to Transform CRISPR Gene-Editing...

3/19/2025China's Healthcare Sector in 2025: Anti-Corruption and Beyond (CR)

3/19/2025Severe Decline in County Market in 2024, Possible Rebound in 2025, wit...

3/17/2025HBM and Insilico Enter Strategic Deal to Advance AI-Driven Antibody Di...

3/17/2025BeiGene and Amgen Launch Phase 1 Trial of Tarlatamab + YL201 in China

3/17/2025China Suspends Imports of Five APIs from Kyowa Hakko Bio's Hofu Plant

3/17/2025NMPA Solicits Comments on Draft Revision of GMP Annex for Sterile Drug...

3/17/2025Innovent Launches GLORY-3: A Phase 3 Head-to-Head Study of Mazdutide v...

3/14/2025BioCity Announces Clinical Collaboration to Evaluate BC3195 in Combo w...

3/14/2025Fosun Pharma to Divest United Family Healthcare for $124.1M

3/14/2025Zai Lab/Pfizer's BLA for Tivdak Accepted in China

3/14/2025Innovent's IBI311 Becomes First Chinese-Made IGF-1R Antibody Approved ...

3/14/2025Recent Executive Moves

3/14/2025PharmCube's Overview and Insights into China's Pharmaceutical Market 2...

Page:10/361 Total number of articles:10820: [First][<<] [8] [9] [10] [11] [12] [>>] [End]